MW Biogen shares slump as multiple-sclerosis-drug sales disappoint
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 12, 2025 13:05 ET (18:05 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.